Sequence variation displayed by the human immunodeficiency virus type 1 (HIV-1) has been proposed to be linked to the pathogenesis of acquired immunodeficiency syndrome (AIDS). To assess viral evolution during the course of infection, we evaluated sequence variability in the env variable domains in four HIV-1-infected individuals exhibiting differing profiles of CD4 ϩ T cell decline when followed from seroconversion until the development of AIDS or loss of followup. Proviral sequences encoding the V3±V5 region of gp120 were obtained following PCR amplification of peripheral blood mononuclear cell DNA and cloning. Virus in each patient was relatively homogeneous early in infection and then diverged with time, more consistently at its nonsynonymous sites. Just prior to or coincident with a rapid decline in CD4 ϩ T cell numbers, sequences were found with basic amino acid substitutions clustered within and downstream of the gp120 V3 domain. Within the constraints of the current dataset, we conclude that the virus appears to continually accumulate changes in its amino acid sequences well into the time of marked CD4 ϩ T cell decline.
INTRODUCTION
Accumulation of genetically diverse viral genome variants in vivo is a hallmark of lentivirus replication. Genetic variants, introduced by the high error rate of retroviral reverse transcriptase, are selected for by conformational constraints imposed by viral structure, function, and immune pressure (Borrow et al., 1997; Hirsch et al., 1989) . In HIV-1, considerable variation is focused in the envelope gene, which encodes critical host±range determinants and immune targets on the virus.
Minimal viral env gene heterogeneity is observed early in infection via homosexual, parenteral, and perinatal transmission routes (Ganeshan et al., 1997; McNearney et al., 1992; Wolfs et al., 1992; Wolinsky et al., 1992 Wolinsky et al., , 1996 Zhang et al., 1993; Zhu et al., 1993) . This suggests the presence of a viral population bottleneck resulting in the establishment of infection by a single infectious unit or a selective amplification of only one or a few variants. However, over the course of the disease, the virus population turns over rapidly Perelson et al., 1996; Wei et al., 1995) and evolves to diverge 5±10% or more within an individual and yet retain signature sequences identifying their phylogenetic origin.
The rate of disease progression in HIV-1 and related infections has been associated with several factors. These include the magnitude of viral load (Mellors et al., 1996) , enhancement of viral transcription and replication (Connor and Ho, 1994; Furtado et al., 1995; Michael et al., 1991; Saksela et al., 1994) , emergence of more cytopathic or pathogenic variants (Connor et al., 1993; Dewhurst et al., 1990; Mullins et al., 1991; Schuitemaker et al., 1992; Tersmette et al., 1988 Tersmette et al., , 1989 , alterations in immune parameters (Klein et al., 1995; Rinaldo et al., 1995) , and in cases of slow disease progression, transmission or persistence of attenuated forms of the virus (Connor and Ho, 1994; Deacon et al., 1995; Desrosiers, 1992; Iversen et al., 1995; Kirchhoff et al., 1995; Michael et al., 1991) or the mutant form of the chemokine co-receptors (Smith et al., 1997) . Disease progression has also been proposed to result from attainment of a threshold of antigenic diversity in the viral quasispecies above which the immune system is unable to respond (Nowak et al., 1991) . Clonal dominance or deceptive imprinting of the immune response toward the viruses established early in infection, aided in part by a saturating level of circulating viral antigen, has also been proposed to result in a loss of immune containment and disease progression (Ko Èhler et al., 1992 (Ko Èhler et al., , 1994 . Viral genetic diversity tends to evolve more slowly in those progressing relatively quickly to AIDS (Delwart et al., 1994; Liu et al., 1997; Lukashov et al., 1995; Wolinsky et al., 1996) . The hypothesis that early phases of disease progression are dominated by a bias in viral evolutionary progression for nonsynonymous site changes, then for synonymous changes when the immune system collapses, has also been put forward , although this analysis is controversial .
To address the association between viral sequence variability and disease progression, we evaluated the evolution of sequences spanning the V3 through V5 variable domains of the HIV-1 envelope gene in four patients with differing clinical courses over the first 5±9 years of their infection. We found low sequence diversity in the virus population from each patient early in infection, followed by viral diversification. Nonsynonymous and synonymous site substitutions increased over time, although notable differences in these trends were observed between patients. When compared to sequences from the virus at seroconversion, all patients showed consistent increases in nonsynonymous substitutions. Within the constraints of a small dataset and the length of followup, our findings fail to show consistent selection for amino acid sequence change early in infection, followed by purifying selection during later stages of the disease . Rather, the amino acid changes continue to accumulate into the time of marked CD4 ϩ T cell decline as examined in this study. Figure 1 illustrates the profile of CD4 ϩ T cell numbers and diversity in viral nucleotide and deduced amino acid sequences found within each time point for each of the four patients studied, as well as these changes relative to sequences sampled at the seroconversion time point. Phylogenetic analysis showed that sequences from each patient clustered into single well-supported separate branches consistent with a lack of contamination between patient samples (data not shown) .
RESULTS
Patient AD progressed to a CD4 ϩ T cell level below 200 in less than 6 years following infection, whereas patients IN and OT progressed somewhat slower, dropping below 200 CD4 ϩ T cell/mm 3 at about 7 years postinfection. Patient EH was lost to followup after 4.5 years of infection with high CD4 cell levels (Ͼ800). AZT was administered to patients AD, IN, and OT, but was not a factor in sequence evaluations for patients AD and OT, since the samples evaluated here were obtained before or at the time of drug administration.
The diversity of viral sequences at each time point generally increased over time (Fig. 1) , notable exceptions being timepoint G in patient EH and to a lesser extent timepoint Q in patient OT. At these two timepoints, many of the sequences formed a tight grouping as a result of low nucleotide divergences (0.35% for timepoint G and 1.69% for timepoint Q), including some identical sequences (Fig. 3b: g6, g8, g9; Fig. 3d: q1, q6) . The level of divergence observed in these clusters is consistent with the error rate of Taq polymerase in PCR (Eckert and Kunkel, 1991) and, since the proviral copy number in the PCR was not quantitated prior to deriving clones, it is likely that these sequences resulted from resampling of the same provirus and thus provide a falsely low estimate of viral population diversity (Liu et al., 1996) . Amino acid diversity increased over the course of infection but was somewhat variable within timepoints. The rate of diversification relative to the first timepoint, however, was more consistent. Similar trends were observed when nucleotide substitutions were evaluated. The rate of virus population diversification was relatively consistent over time, although if anything, a slower rate of change was observed in the patient that had not progressed to disease (patient EH; Fig. 1 ).
An alignment of amino acid sequences sampled from these patients (Fig. 2) shows a pattern of unique mutations superimposed on a pattern of consistent changes that in many instances distinguished different timepoints (e.g., note the 12 consistent amino acid substitutions at the last timepoint in patient AD). For each patient, a separate cluster with considerable bootstrap support was found at later stages of the observation period (Fig.  3) . Thus, the virus populations appeared to have undergone bottlenecks or substantial replacements over time.
Partitioning the sequence variation into changes that lead to altered amino acid sequence (dN) or silent substitutions (dS) is thought to reveal the nature of evolutionary forces acting on the virus population. An overriding selective pressure for change of amino acids is expected to be reflected in the preferential accumulation of dN substitutions. The intra timepoint profile of both dN and dS substitutions (Fig. 1B ) was quite variable with either high dS substitutions (patients AD and IN) or high dN substitutions (patients EH and OT). However, as shown in Fig. 1C , when the variability at dN and dS sites was compared to sequences from virus at the first timepoint, dN substitutions showed a strong tendency to increase in a linear manner in all the patients, identical to that seen with amino acid variations (Fig. 1A) . On the other hand, the divergence in dS substitutions at each timepoint compared to virus present early in infection (Fig. 1C) were as variable as that seen for intra time point profiles (Fig. 1B) . Therefore, these results suggest that virus is constantly accumulating dN substitutions as it evolves over time.
The presence of a more heterogeneous viral population in slow progressors versus rapid progressors has been reported (Delwart et al., 1994; Wolinsky et al., 1996) . However, patient EH, who appears to have maintained stable CD4 ϩ T cell numbers over the period evaluated, shows relatively low overall virus variation. No consistent changes associated with N-glycosylation motifs were noted. For example, in patient AD, of the 12 motifs, only one position accumulated changes in three or more sequences over time that resulted in a loss of the Nglycosylation site.
Certain amino acid positions have been shown to determine important in vitro HIV phenotypic properties. Extending previously published observations, Milich et al., (1993) reported a statistically significant association between the presence of basic amino acid substitutions at four positions in V3 and the T-cell tropism of viral isolates. All four patients show basic substitutions at one or more of these positions toward later stages of infection (Fig. 2) . Similarly, the amino acid at position seven in V3 loop alignment shown in Fig. 2 (I?IGPGR) was reported to be associated with V3 peptide binding and either resistance or enhancement of infection by human monoclonal antibodies (Kliks et al., 1993) . Variation at this position can be seen in all patients except patient EH.
DISCUSSION
Pathogens such as HIV-1 survive in part by changing their genetic structure rapidly to overcome host defenses and antiretroviral agents. However, such variation is limited by the constraints of a conformational framework that requires viral proteins to retain their function. The chronic nature of an HIV-1 infection, the high replicative error rate, and the extremely large turnover of virus Perelson et al., 1996; Wei et al., 1995) allow the virus population to accumulate a large number of mutations. To understand the differences in disease progression observed in HIV-1-infected individuals, as well as the dynamics of sequence variation, a longitudinal sampling of viral sequences within four individuals with differing disease progression profiles was conducted.
In agreement with previous reports (Delwart et al., 1994; McNearney et al., 1992; Pang et al., 1992; Wolfs et al., 1992; Wolinsky et al., 1992 Wolinsky et al., , 1996 Zhang et al., 1993; Zhu et al., 1993) , all four patients showed relatively low levels of sequence heterogeneity at the first timepoint postseroconversion. Thereafter, the viral quasispecies In each alignment, dots indicate identity with the consensus sequence and dashes indicate a deletion at the position corresponding to the consensus sequence.
The amino acid sequences span V3, V4, and V5 domains of env as indicated at the top of the alignment. Four amino acids in the V3 loop that are highlighted with asterisks indicate those suggested to be significantly associated with altered tropism (Milich et al., 1993) . Amino acids indicated with a carat correspond to putative N-glycosylation sequences.
FIG. 3.
Phylogenetic relationships among nucleic acid sequences sampled in each patient. The phylogenetic trees were generated using the neighbor-joining method (Saitou and Nei, 1987) from the matrix of DNA distances for pairwise comparisons derived in PHYLIP (Felsenstein, 1993) . Sequences from the clones E2 and C3 and four other prototype viral sequences were used as an outgroup and to root the tree. Numbers at the nodes indicate the percentage of samples (of 1000) in which an indicated node was supported in a bootstrap analysis; values Ն80% are shown.
appear to become more heterogeneous as well as diversify away from the virus population initiating the infection. The dynamics of such evolution can provide keys to a better understanding of the pathogenic process. For example, a constant rate of viral evolution during the entire disease course suggests that host immune status and other host-related parameters are of lesser importance than if deviations from a constant rate during different stages of disease is found. Within the constraints of the length and frequency of followup and the number of sequences examined in this study, there appears to be a gradual and constant level of virus diversification into late stages of infection, where CD4 ϩ T cell numbers decline precipitously. The consistency may be greater than shown in Fig. 1 , if indeed the sample diversity is artificially low due to template resampling.
The antigenic diversity threshold theory (Nowak et al., 1991) predicts that the virus population continues to accumulate mutations in response to immune pressure until a point that the immune response capacity is saturated and fast replicating viral variants are expected to predominate. Alternatively, the evolution of virulent forms of the virus (Connor et al., 1993; Dewhurst et al., 1990; Mullins et al., 1991; Schuitemaker et al., 1992; Tersmette et al., 1988 Tersmette et al., , 1989 ) could be associated with occult replication and ultimate outgrowth of a more virulent variant leading to the development of AIDS. In both of these scenarios, the presence of immune driven selection is expected to be reflected in the preferential accumulation of nonsynonymous substitutions while such a bias would be absent following the advancement of the disease state. The clonal dominance theory (Ko Èhler et al., 1992 (Ko Èhler et al., , 1994 , on the other hand, predicts an absence of selection by the immune pressure since the immune response is directed at the sequences that initiated the infection. A low level of dS relative to dN has been interpreted as evidence for positive selection . Furthermore, when viewed in the context of the presence of a preponderance of synonymous substitutions in viral genes evolving at a fast rate (Gojobori et al., 1990) , it remains to be seen if the presence of equivalent substitutions at dN and dS sites may be considered in itself as evidence of selection for change in amino acid sequence.
In the current study, both dN and dS substitutions generally increase over time at similar rates (Fig. 1) . However, there was no apparent consistency in the trends among the patients. While the presence of positive selection for change over the disease course has been suggested Rodrigo and Mullins, 1996; Wolinsky et al., 1996) , the lack of clearly identifiable patterns of amino acid sequence change among the patients reveals a need to further augment information on sequence variation in terms of its biologic implications.
MATERIALS AND METHODS
Patient selection. Four HIV-1-infected homosexual men were selected from the Pittsburgh cohort of the Multicenter AIDS Cohort Study (MACS). Each PBMC specimen was identified by a letter that was ordered in a series and the patient designators were derived from the first and last letter corresponding to samples from that patient. For example, four samples were obtained from patient AD (samples A, B, C, and D), four for patient EH (samples E, F, G and H), etc. Patients AD and IN showed a marked decline in CD4 ϩ T cell numbers over the course of the first 5 years of infection. Patient EH maintained stable CD4 ϩ T cell numbers for 4.3 years following seroconversion, before loss to followup. Patient OT also maintained stable CD4
ϩ T cells for 6.5 years before experiencing a marked decline leading to AIDS 8.4 years after seroconversion. Zidovudine was administered to three of the patients as indicated in Fig. 1 , but was not a factor in influencing viral diversity estimations in two of these patients. A total of 19 time points from the four individuals were analyzed.
PCR amplification and sequencing. Between 100,000 and 250,000 PBMC were lysed in a quick lysis solution of 0.5% NP-40 and Tween 20 (Ehrlich et al., 1990 ) and used in a nested PCR amplification protocol that reproducibly resulted in amplification of less than 10 copies of template DNA (data not shown). The outer primers used were (7060) 5Ј-CAATGCTAAAACCATAATAGTACA and (7735) 5Ј-TCTTCTCTTTGCCTTGGTGGGT. The internal primer pairs used in a second round of PCR were (7088) 5Ј-AACCAATCTGCAGAAATTAATTGTACGCGTCCCA-ACAAC and (7645) 5Ј-ATCTCCTCCTCCCGGCCGGAA-GATCTCGGA [numbers in parentheses indicate the position of the 5Ј base of the oligonucleotide in the sequence of prototype strain HXB2 (Genbank Accession No. K03455) and the underlined bases correspond to alterations introduced in the primer sequence to facilitate recognition by restriction endonuclease]. Procedural safeguards were employed against sample contamination . Control reactions with no template were included in every amplification experiment to test for the presence of carryover contamination. The specificity of amplified products was established by liquid hybridization using a radioactively labeled oligonucleotide specific for amplified sequences and gel retardation analysis followed by autoradiography (Ehrlich et al., 1990; Sirko, 1994) . Amplified products were cloned into pBluescript (Stratagene, La Jolla, CA) following digestion with restriction endonucleases or into the TA cloning vector pCRII (Invitrogen, San Diego, CA). Plasmids were sequenced on an ABI 373A automated sequencer using cycle sequencing with dye terminator chemistry (Perkin±Elmer; Norwalk CT). From each time point, up to 8 sequences encoding an open reading frame were used for further analysis. A total of 119 sequences were examined and deposited in GenBank (Accession Nos. U15804±U15922).
Sequence analysis. All sequences determined were compared to the GenBank sequence database (Release 91.0) using the FASTA program (Pearson and Lipman, 1988) . The variation among amino acid sequences was computed as a mean of the unweighted Hamming distances between pairs of amino acid sequences using MEGA software (Kumar et al., 1994) . Variation in nucleic acid sequences was computed using the two-parameter distance method of Kimura (1980) , as implemented in the MEGA program (Kumar et al., 1994) .
Phylogenetic relationships among sequences were evaluated using the neighbor-joining method (Saitou and Nei, 1987) implemented in PHYLIP Version 3.5 (Felsenstein, 1993) . Sequences from each patient formed monophyletic groups, with none greater than 93.6% identical to sequences from other patients or those in the GenBank database. These observations are consistent with a lack of sample mix up between individuals and from other strains present in the laboratory .
Proportion of nonsynonymous substitutions per potential nonsynonymous site (dN) and the proportion of synonymous substitutions per potential synonymous site (dS) were calculated with Jukes-Cantor correction using MEGA software (Kumar et al., 1994) .
